SAGAN PAUL

Director · OKTA, MRNA

As of 2026-09-16, SAGAN PAUL has 4 Form 4 transactions on record across 2 companies — 2 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $4.1MIndirect: $45.4M$49.5Mas of 2026-09-16
  • Direct $4.1M
  • Indirect $45.4M
MRNAindirect312,027 sh$45.4M
MRNAdirect25,512 sh$3.7M
OKTAdirect2,080 sh$391K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

OKTA · 2 trades
2026-06-18: Award / grant, 2,080 sh ($0)2025-12-19: Award / grant, 5,876 sh ($0)
MRNA · 2 trades
2025-04-30: Award / grant, 25,512 sh ($0)2025-03-03: Purchase, 31,620 sh ($1.0M)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2025-03-03MRNAPurchase31,620 @ $31.76$1.0M+11.3% of holding312,027Form 4
3 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-06-18OKTAAward / grant2,0802,080Form 4
2025-12-19OKTAAward / grant5,8765,876Form 4
2025-04-30MRNAAward / grant25,51225,512Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.